Developer docs
API playgroundTry for free, no card

Search company profiles

Sanos Group

Full company profile

uuid0059doa

Namestring
Sanos Group
Legal namestring
Sanos Group ApS
Websiteurl
sanos.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Sanos Group is a Denmark-based, multi-niche Contract Research Organization (CRO) founded in 2006 and headquartered in Søborg. The company operates through specialized subsidiaries covering three therapeutic niches: NBCD (musculoskeletal), Neuroscios (neurological diseases including Alzheimer's, Parkinson's, and ALS), and Blueskin (dermatology including psoriasis and atopic dermatitis). Its service portfolio spans the full clinical trial lifecycle, including Phase I clinical pharmacology through Sanos Clinic, GMP-certified clinical trial supply and depot services through Sanos Supply, and proprietary electronic Clinical Outcome Assessment (eCOA) technology through Studies&Me, which was spun out from Nordic Bioscience's IT operations in 2021.

The company employs approximately 250 staff across operations in Denmark, Germany, and the USA, with active clinical trial reach extending to over 35 countries. Sanos serves pharmaceutical companies, biotech firms, and academic institutions under a fixed-budget pricing model, with revenue derived from professional services, managed services, and recurring eCOA subscription contracts. The leadership team, led by Group CEO Jeppe Ragnar Andersen, brings 20-30 years of therapeutic expertise, supported by 200+ peer-reviewed publications and a track record of 18,000+ patients in studies led by the CEO.

Since 2020, Sanos has executed a roll-up strategy funded by a majority investment from InvestCorp, acquiring three niche CROs and vertically integrating Phase I capabilities, supply chain, and eCOA technology. The company's strategic focus is on building a differentiated, multi-niche CRO platform that combines deep therapeutic expertise, integrated technology, and GMP-certified infrastructure to compete with full-service global CROs in specialized indications.

Short descriptiontext

Sanos Group is a Denmark-based multi-niche CRO serving pharmaceutical, biotech, and academic clients across 35+ countries, specializing in musculoskeletal, neurological, and dermatological clinical trials with integrated Phase I, GMP depot, and eCOA technology capabilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSøborg, Denmark
HQ citystring
Søborg
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, contract research organization, clinical trial management, electronic clinical outcome assessment, patient recruitment services
Industry4 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
Product category
Clinical Research Services (Contract Research Organization)
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Full-Service CRO Services
TypeProfessional Services
Description

Comprehensive clinical trial management services from study feasibility and protocol design to regulatory affairs, risk-based monitoring, and statistical analysis. Services span early-phase development through large-scale Phase I-III trials with fixed-budget pricing model.

sanos.com
2Clinical Supply Logistics
TypeManaged Services
Description

GMP-certified storage, packaging, labeling, and global distribution services for investigational medicinal products through Sanos Supply division.

sanos.com
3eCOA Technology Solutions
TypeSubscription Recurring
Description

Electronic Clinical Outcome Assessment solutions including AnneaPRO and eDairy platforms for data collection in clinical trials.

sanos.com
4Research Clinic Services
TypeProfessional Services
Description

Patient recruitment, site management, and clinical trial execution services through Sanos Clinic network with dedicated Phase I unit.

sanos.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Fixed Budget Model
ModelOtherBilling cadenceMulti-year contract
Notes

Fixed-budget pricing model providing financial security and eliminating cost overruns. Specific pricing tiers and rates are not publicly disclosed; quotes are provided based on study requirements.

sanos.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Sanos Group is a multi-niche Contract Research Organization that plans and runs clinical trials for pharmaceutical and biotechnology sponsors across musculoskeletal, neurological, and dermatological therapeutic areas. Its offering spans full-service clinical trial management, eCOA technology (AnneaPRO, eDairy), digital patient recruitment (Studies&Me), a GMP-certified clinical supply depot (Sanos Supply), and dedicated research clinics including a Phase I unit (Sanos Clinic), delivered under fixed-budget, fixed-timeline contracts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • One of the highest patient retention rates in clinical trials
+2 more records
Product and service6 records
1Full-Service CRO Services
CategoryClinical Research Services
2eCOA Solutions (AnneaPRO and eDairy)
CategoryClinical Trial Technology
3Sanos Supply (GMP Clinical Trial Supply)
CategoryClinical Trial Logistics
4Patient Recruitment (Studies&Me)
CategoryPatient Recruitment Services
5Sanos Clinic (Research Clinics with Phase I Unit)
CategoryClinical Trial Site Services
6Biostatistics and Data Science Services
CategoryData and Statistical Analysis
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large clinical-to-commercial CRO with significant biotech sponsor focus, currently privately held following Elliott/Patient Square take-private. Comparable scale tier and full-service CRO scope competing for Sanos' enterprise sponsor relationships.

TypeBroad incumbent
Description

Large publicly traded CRO/CDMO offering preclinical through clinical research services globally. Comparable end-to-end clinical and supply chain capabilities (Sanos Supply mirrors parts of Charles River's manufacturing/distribution), but with significantly broader scope and scale.

TypeDirect peer
Description

Mid-sized, therapeutically focused full-service CRO with strong margins and a science-led operating model. Highly comparable to Sanos in therapeutic specialization strategy, mid-tier scale, and B2B pharma/biotech sponsor focus, though materially larger (~5,500+ employees).

TypeBroad incumbent
Description

Top-tier global CRO offering full-service clinical development including biotech-focused PRA Health Sciences division. Comparable end-to-end service model competing for the same enterprise sponsor contracts as Sanos.

TypeBroad incumbent
Description

Largest global full-service CRO with R&D Solutions and technology platforms. Direct competitor for large enterprise Phase III trials Sanos is targeting, and a comparable provider of clinical supply, eCOA, and real-world data services.

TypeDirect peer
Description

Specialty early-phase clinical research organization with dedicated Phase I clinic network and bioanalytical lab services. Comparable to Sanos Clinic's Phase I unit and Sanos' early-phase clinical development focus.

TypeDirect peer
Description

Specialty CRO focused on biotech and rare disease trials across multiple therapeutic areas including neuroscience and dermatology. Comparable multi-niche specialty model serving small-to-mid biotech sponsors with similar scope to Sanos.

TypeDirect peer
Description

Privately held, mid-sized multi-niche CRO with therapeutic focus in neuroscience, cardiometabolic, and rare diseases. Closely comparable to Sanos' multi-niche specialty positioning and similar employee scale (~1,500-2,000).

TypeDirect peer
Description

Leading provider of eCOA, cardiac safety, and clinical endpoint technology solutions formed from ERT and Bioclinica merger. Most direct competitor to AnneaPRO and eDairy eCOA platforms within Sanos' technology portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sanos Group

Clinical Research Services (Contract Research Organization)sanos.com

Sanos Group is a Denmark-based multi-niche CRO serving pharmaceutical, biotech, and academic clients across 35+ countries, specializing in musculoskeletal, neurological, and dermatological clinical trials with integrated Phase I, GMP depot, and eCOA technology capabilities.

What Sanos Group does

Sanos Group is a Denmark-based, multi-niche Contract Research Organization (CRO) founded in 2006 and headquartered in Søborg. The company operates through specialized subsidiaries covering three therapeutic niches: NBCD (musculoskeletal), Neuroscios (neurological diseases including Alzheimer's, Parkinson's, and ALS), and Blueskin (dermatology including psoriasis and atopic dermatitis). Its service portfolio spans the full clinical trial lifecycle, including Phase I clinical pharmacology through Sanos Clinic, GMP-certified clinical trial supply and depot services through Sanos Supply, and proprietary electronic Clinical Outcome Assessment (eCOA) technology through Studies&Me, which was spun out from Nordic Bioscience's IT operations in 2021.

The company employs approximately 250 staff across operations in Denmark, Germany, and the USA, with active clinical trial reach extending to over 35 countries. Sanos serves pharmaceutical companies, biotech firms, and academic institutions under a fixed-budget pricing model, with revenue derived from professional services, managed services, and recurring eCOA subscription contracts. The leadership team, led by Group CEO Jeppe Ragnar Andersen, brings 20-30 years of therapeutic expertise, supported by 200+ peer-reviewed publications and a track record of 18,000+ patients in studies led by the CEO.

Since 2020, Sanos has executed a roll-up strategy funded by a majority investment from InvestCorp, acquiring three niche CROs and vertically integrating Phase I capabilities, supply chain, and eCOA technology. The company's strategic focus is on building a differentiated, multi-niche CRO platform that combines deep therapeutic expertise, integrated technology, and GMP-certified infrastructure to compete with full-service global CROs in specialized indications.

Sanos Group firmographics

Firmographics
Name
Sanos Group
Legal name
Sanos Group ApS
Website
https://sanos.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
101–250 employees
Short description
Sanos Group is a Denmark-based multi-niche CRO serving pharmaceutical, biotech, and academic clients across 35+ countries, specializing in musculoskeletal, neurological, and dermatological clinical trials with integrated Phase I, GMP depot, and eCOA technology capabilities.
Ownership category
akta.pro rank

Sanos Group industry classification

Industry
Product category
Clinical Research Services (Contract Research Organization)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs

Keywords

  • Clinical research services
  • Contract research organization
  • Clinical trial management
  • Electronic clinical outcome assessment
  • Patient recruitment services

Where Sanos Group is headquartered

Location

Headquarters

HQ city
Søborg
HQ country
Denmark
HQ region
Europe

Offices4 records

Markets served

Sanos Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Full-Service CRO Services: Comprehensive clinical trial management services from study feasibility and protocol design to regulatory affairs, risk-based monitoring, and statistical analysis. Services span early-phase development through large-scale Phase I-III trials with fixed-budget pricing model.
  2. Clinical Supply Logistics: GMP-certified storage, packaging, labeling, and global distribution services for investigational medicinal products through Sanos Supply division.
  3. eCOA Technology Solutions: Electronic Clinical Outcome Assessment solutions including AnneaPRO and eDairy platforms for data collection in clinical trials.
  4. Research Clinic Services: Patient recruitment, site management, and clinical trial execution services through Sanos Clinic network with dedicated Phase I unit.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFixed Budget Model

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Sanos Group product offering

Product offering

Core offering

Sanos Group is a multi-niche Contract Research Organization that plans and runs clinical trials for pharmaceutical and biotechnology sponsors across musculoskeletal, neurological, and dermatological therapeutic areas. Its offering spans full-service clinical trial management, eCOA technology (AnneaPRO, eDairy), digital patient recruitment (Studies&Me), a GMP-certified clinical supply depot (Sanos Supply), and dedicated research clinics including a Phase I unit (Sanos Clinic), delivered under fixed-budget, fixed-timeline contracts.

Differentiator

Problem solved

Functional benefit

Products and services

  • Full-Service CRO Services
  • eCOA Solutions (AnneaPRO and eDairy)
  • Sanos Supply (GMP Clinical Trial Supply)
  • Patient Recruitment (Studies&Me)
  • Sanos Clinic (Research Clinics with Phase I Unit)
  • Biostatistics and Data Science Services

Quantifiable outcome

  • One of the highest patient retention rates in clinical trials
  • +2 more outcomes

Companies that use Sanos Group

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Sanos Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Sanos Group partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves10 records

Expansion highlights5 records

Sanos Group competitors and assessment

Company assessment

Broad incumbents

  • Syneos Health: Large clinical-to-commercial CRO with significant biotech sponsor focus, currently privately held following Elliott/Patient Square take-private. Comparable scale tier and full-service CRO scope competing for Sanos' enterprise sponsor relationships.
  • Charles River Laboratories: Large publicly traded CRO/CDMO offering preclinical through clinical research services globally. Comparable end-to-end clinical and supply chain capabilities (Sanos Supply mirrors parts of Charles River's manufacturing/distribution), but with significantly broader scope and scale.
  • ICON plc: Top-tier global CRO offering full-service clinical development including biotech-focused PRA Health Sciences division. Comparable end-to-end service model competing for the same enterprise sponsor contracts as Sanos.
  • IQVIA: Largest global full-service CRO with R&D Solutions and technology platforms. Direct competitor for large enterprise Phase III trials Sanos is targeting, and a comparable provider of clinical supply, eCOA, and real-world data services.

Direct peers

  • Medpace Holdings: Mid-sized, therapeutically focused full-service CRO with strong margins and a science-led operating model. Highly comparable to Sanos in therapeutic specialization strategy, mid-tier scale, and B2B pharma/biotech sponsor focus, though materially larger (~5,500+ employees).
  • Celerion: Specialty early-phase clinical research organization with dedicated Phase I clinic network and bioanalytical lab services. Comparable to Sanos Clinic's Phase I unit and Sanos' early-phase clinical development focus.
  • Premier Research: Specialty CRO focused on biotech and rare disease trials across multiple therapeutic areas including neuroscience and dermatology. Comparable multi-niche specialty model serving small-to-mid biotech sponsors with similar scope to Sanos.
  • Worldwide Clinical Trials: Privately held, mid-sized multi-niche CRO with therapeutic focus in neuroscience, cardiometabolic, and rare diseases. Closely comparable to Sanos' multi-niche specialty positioning and similar employee scale (~1,500-2,000).
  • Clario: Leading provider of eCOA, cardiac safety, and clinical endpoint technology solutions formed from ERT and Bioclinica merger. Most direct competitor to AnneaPRO and eDairy eCOA platforms within Sanos' technology portfolio.

Others

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Sanos Group social profiles

Digital presence

Sanos Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sanos Group leadership team

Management profile

Number of profiles

Profiles17 records

Sanos Group subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Sanos Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sanos Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanos Group

What does Sanos Group do?

Sanos Group is a multi-niche Contract Research Organization that plans and runs clinical trials for pharmaceutical and biotechnology sponsors across musculoskeletal, neurological, and dermatological therapeutic areas. Its offering spans full-service clinical trial management, eCOA technology (AnneaPRO, eDairy), digital patient recruitment (Studies&Me), a GMP-certified clinical supply depot (Sanos Supply), and dedicated research clinics including a Phase I unit (Sanos Clinic), delivered under fixed-budget, fixed-timeline contracts.

Is Sanos Group a public or private company?

Sanos Group is a private company. It is classified as private equity controlled and is currently operating.

When was Sanos Group founded?

Sanos Group was founded in 2006. It employs 101 to 250 people.

Where is Sanos Group based?

Sanos Group is headquartered in Søborg, Denmark, in the Europe region.

How does Sanos Group make money?

Four revenue lines are on record. Full-Service CRO Services are the primary driver. The others are clinical Supply Logistics, eCOA Technology Solutions and research Clinic Services.

Who are Sanos Group's main competitors?

Broad incumbents on record are Syneos Health, Charles River Laboratories, ICON plc and IQVIA. Direct peers are Medpace Holdings, Celerion, Premier Research, Worldwide Clinical Trials and Clario. Medidata Solutions (Dassault Systèmes) is listed as an others.

Does Sanos Group have an API?

No public API is recorded for Sanos Group.

What industry is Sanos Group in?

Sanos Group's product category is Clinical Research Services (Contract Research Organization). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals